IceCure Medical Free Cash Flow (FCF) History (ICCM)

IceCure Medical reported −$14.6M in free cash flow for fiscal 2025, a decrease of $2.0M from the previous fiscal year, with a free cash flow margin of −432.38%.

View full IceCure Medical company overview

IceCure Medical free cash flow by year

IceCure Medical annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$14.6M−$2.0M−432.38%
20242024-12-31−$12.6M$396,000−383.90%
20232023-12-31−$13.0M$2.2M−403.53%
20222022-12-31−$15.2M−$2.0M−492.16%
20212021-12-31−$13.1M−$9.2M−317.50%
20202020-12-31−$3.9M−$1.8M−101.16%
20192019-12-31−$2.1M−128.58%

IceCure Medical free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from −$3.9M to −$14.6M, a net decrease of $10.7M.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review IceCure Medical filings at SEC.gov ↗